↓ Skip to main content

Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome

Overview of attention for article published in Cochrane database of systematic reviews, November 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
5 news outlets
twitter
20 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
131 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
Published in
Cochrane database of systematic reviews, November 2014
DOI 10.1002/14651858.cd006105.pub3
Pubmed ID
Authors

Leopoldo O Tso, Michael F Costello, Luiz Eduardo T Albuquerque, Régis B Andriolo, Cristiane R Macedo

Abstract

The use of insulin-sensitising agents, such as metformin, in women with polycystic ovary syndrome (PCOS) who are undergoing ovulation induction or in vitro fertilisation (IVF) cycles has been widely studied. Metformin reduces hyperinsulinaemia and suppresses the excessive ovarian production of androgens. As a consequence, it is suggested that metformin could improve assisted reproductive techniques (ART) outcomes, such as ovarian hyperstimulation syndrome (OHSS), pregnancy and live birth rates.

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ethiopia 1 <1%
United States 1 <1%
Unknown 129 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 17%
Student > Master 22 17%
Student > Bachelor 21 16%
Student > Ph. D. Student 19 15%
Other 16 12%
Other 31 24%
Readers by discipline Count As %
Medicine and Dentistry 76 58%
Unspecified 16 12%
Agricultural and Biological Sciences 11 8%
Nursing and Health Professions 8 6%
Social Sciences 8 6%
Other 12 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 56. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2019.
All research outputs
#277,186
of 12,814,036 outputs
Outputs from Cochrane database of systematic reviews
#774
of 10,429 outputs
Outputs of similar age
#6,796
of 292,679 outputs
Outputs of similar age from Cochrane database of systematic reviews
#25
of 252 outputs
Altmetric has tracked 12,814,036 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,429 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.4. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,679 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 252 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.